{"id":5563,"date":"2025-02-03T09:53:05","date_gmt":"2025-02-03T08:53:05","guid":{"rendered":"https:\/\/cnatm-1.betapage.de\/?p=5563"},"modified":"2025-02-03T09:53:59","modified_gmt":"2025-02-03T08:53:59","slug":"peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika","status":"publish","type":"post","link":"https:\/\/cnatm.de\/en\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/","title":{"rendered":"Peptide-coupled antisense oligonucleotides as a new class of antibiotics"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5563\" class=\"elementor elementor-5563\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6363f8b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6363f8b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-807a88d\" data-id=\"807a88d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0b60e27 elementor-widget elementor-widget-heading\" data-id=\"0b60e27\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Peptide-coupled antisense oligonucleotides as a new class of antibiotics<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-39021d3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"39021d3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3c861fc\" data-id=\"3c861fc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-553a889 elementor-widget elementor-widget-spacer\" data-id=\"553a889\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39a4d74 elementor-widget elementor-widget-text-editor\" data-id=\"39a4d74\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The widespread use of classical antibiotics carries the risk of multi-resistance and also leads to unwanted side effects such as damage to the natural bacterial flora. In this subproject, highly selective RNA antibiotics are being developed as a novel approach for the targeted control of pathogenic bacteria. Antisense oligonucleotides are coupled to peptides that bind to specific surface structures of the bacteria, thus enabling the oligonucleotide to be introduced.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-72d739a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"72d739a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-89f255c\" data-id=\"89f255c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-89a1439 elementor-widget elementor-widget-text-editor\" data-id=\"89a1439\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Head: J\u00f6rg Vogel<br \/><\/strong><\/p><p>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-4e4729f\" data-id=\"4e4729f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora. In diesem Teilvorhaben werden hochselektive RNA-Antibiotika als neuartiger Ansatz zur gezielten Bek\u00e4mpfung pathogener Bakterien entwickelt. Hierbei werden Antisense-Oligonukleotide an Peptide gekoppelt, die an spezifische Oberfl\u00e4chenstrukturen [&hellip;]<\/p>","protected":false},"author":11,"featured_media":5564,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[74],"tags":[],"class_list":["post-5563","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oligonukleotide-und-ihr-gezieltes-delivery"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika - CNATM<\/title>\n<meta name=\"description\" content=\"Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnatm.de\/en\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika - CNATM\" \/>\n<meta property=\"og:description\" content=\"Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnatm.de\/en\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\" \/>\n<meta property=\"og:site_name\" content=\"CNATM\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-03T08:53:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-03T08:53:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png\" \/>\n\t<meta property=\"og:image:width\" content=\"916\" \/>\n\t<meta property=\"og:image:height\" content=\"660\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Patrizia Torelli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrizia Torelli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\"},\"author\":{\"name\":\"Patrizia Torelli\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\"},\"headline\":\"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika\",\"datePublished\":\"2025-02-03T08:53:05+00:00\",\"dateModified\":\"2025-02-03T08:53:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\"},\"wordCount\":83,\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png\",\"articleSection\":[\"Oligonukleotide und ihr gezieltes Delivery\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\",\"url\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\",\"name\":\"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika - CNATM\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png\",\"datePublished\":\"2025-02-03T08:53:05+00:00\",\"dateModified\":\"2025-02-03T08:53:59+00:00\",\"description\":\"Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png\",\"width\":916,\"height\":660,\"caption\":\"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cnatm.de\/#website\",\"url\":\"https:\/\/cnatm.de\/\",\"name\":\"CNATM\",\"description\":\"Cluster for Nucleic Acid Therapeutics Munich\",\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cnatm.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cnatm.de\/#organization\",\"name\":\"CNATM\",\"url\":\"https:\/\/cnatm.de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"width\":2362,\"height\":479,\"caption\":\"CNATM\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\",\"name\":\"Patrizia Torelli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"caption\":\"Patrizia Torelli\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika - CNATM","description":"Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnatm.de\/en\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/","og_locale":"en_US","og_type":"article","og_title":"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika - CNATM","og_description":"Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora.","og_url":"https:\/\/cnatm.de\/en\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/","og_site_name":"CNATM","article_published_time":"2025-02-03T08:53:05+00:00","article_modified_time":"2025-02-03T08:53:59+00:00","og_image":[{"width":916,"height":660,"url":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png","type":"image\/png"}],"author":"Patrizia Torelli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrizia Torelli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#article","isPartOf":{"@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/"},"author":{"name":"Patrizia Torelli","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e"},"headline":"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika","datePublished":"2025-02-03T08:53:05+00:00","dateModified":"2025-02-03T08:53:59+00:00","mainEntityOfPage":{"@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/"},"wordCount":83,"publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"image":{"@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png","articleSection":["Oligonukleotide und ihr gezieltes Delivery"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/","url":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/","name":"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika - CNATM","isPartOf":{"@id":"https:\/\/cnatm.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage"},"image":{"@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png","datePublished":"2025-02-03T08:53:05+00:00","dateModified":"2025-02-03T08:53:59+00:00","description":"Der breite Einsatz klassischer Antibiotika birgt das Risiko von Multiresistenzen und f\u00fchrt zudem zu ungewollten Nebenwirkungen wie z.B. der Sch\u00e4digung der nat\u00fcrlichen Bakterienflora.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/peptid-gekoppelte-antisense-oligonukleotide-als-neue-klasse-von-antibiotika\/#primaryimage","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP11.png","width":916,"height":660,"caption":"Peptid-gekoppelte Antisense-Oligonukleotide als neue Klasse von Antibiotika"},{"@type":"WebSite","@id":"https:\/\/cnatm.de\/#website","url":"https:\/\/cnatm.de\/","name":"CNATM","description":"Cluster for Nucleic Acid Therapeutics Munich","publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnatm.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cnatm.de\/#organization","name":"CNATM","url":"https:\/\/cnatm.de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","width":2362,"height":479,"caption":"CNATM"},"image":{"@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e","name":"Patrizia Torelli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","caption":"Patrizia Torelli"}}]}},"_links":{"self":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5563","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/comments?post=5563"}],"version-history":[{"count":4,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5563\/revisions"}],"predecessor-version":[{"id":5568,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5563\/revisions\/5568"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media\/5564"}],"wp:attachment":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media?parent=5563"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/categories?post=5563"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/tags?post=5563"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}